American Well Financials
AMWL Stock | USD 7.81 0.01 0.13% |
Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
---|---|---|---|---|---|---|---|---|---|
Current Ratio | 5.29 | 2.849 |
|
|
Investors should never underestimate American Well's ability to pay suppliers on time, ensure interest payments are not accumulating, and correctly time where and how to reinvest extra cash. Individual investors need to monitor American Well's cash flow, debt, and profitability to make informed and accurate decisions about investing in American Well Corp.
Net Income |
|
American | Select Account or Indicator |
Understanding current and past American Well Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of American Well's financial statements are interrelated, with each one affecting the others. For example, an increase in American Well's assets may result in an increase in income on the income statement.
American Well Stock Summary
American Well competes with Doximity, Certara, Teladoc, Definitive Healthcare, and Schrodinger. American Well Corporation operates as a telehealth software company that enables digital delivery of care for healthcare. American Well Corporation was incorporated in 2006 and is headquartered in Boston, Massachusetts. American Well operates under Health Information Services classification in the United States and is traded on New York Stock Exchange. It employs 1035 people.Specialization | Health Care, Health Care Equipment & Services |
Instrument | USA Stock View All |
Exchange | New York Stock Exchange |
ISIN | US03044L1052 |
CUSIP | 03044L105 03044L204 |
Location | Massachusetts; U.S.A |
Business Address | 75 State Street, |
Sector | Health Care Equipment & Supplies |
Industry | Health Care |
Benchmark | Dow Jones Industrial |
Website | business.amwell.com |
Phone | 617 204 3500 |
Currency | USD - US Dollar |
American Well Key Financial Ratios
Return On Equity | -0.53 | ||||
Profit Margin | (0.82) % | ||||
Operating Margin | (0.31) % | ||||
Price To Sales | 0.48 X | ||||
Revenue | 254.36 M |
American Well Key Balance Sheet Accounts
2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
Total Assets | 1.4B | 1.4B | 1.2B | 589.7M | 436.0M | 692.0M | |
Other Current Liab | 35.8M | 56.8M | 51.2M | 39.0M | 49.3M | 41.6M | |
Other Liab | 11.2M | 8.2M | 28.6M | 7.9M | 7.1M | 13.8M | |
Net Tangible Assets | (564.5M) | 974.7M | 644.1M | 493.6M | 567.7M | 596.0M | |
Net Debt | (934.0M) | (729.8M) | (523.7M) | (360.3M) | (220.1M) | (231.1M) | |
Retained Earnings | (582.4M) | (811.3M) | (1.1B) | (1.8B) | (2.0B) | (1.9B) | |
Accounts Payable | 5.8M | 12.2M | 7.2M | 4.9M | 5.0M | 7.2M | |
Cash | 941.6M | 746.4M | 538.5M | 372.0M | 228.3M | 216.9M | |
Other Assets | 4.3M | 10.1M | 4.5M | 6.2M | 7.1M | 6.3M | |
Net Receivables | 45.3M | 51.4M | 58.4M | 54.1M | 71.9M | 54.1M | |
Inventory | 9.1M | 7.5M | 8.7M | 6.7M | 2.9M | 2.7M | |
Other Current Assets | 17.3M | 22.0M | 40.5M | 16.7M | 13.9M | 20.6M | |
Total Liab | 130.4M | 185.0M | 133.7M | 109.5M | 119.7M | 113.7M | |
Net Invested Capital | 1.2B | 1.2B | 1.1B | 464.2M | 304.8M | 590.4M | |
Total Current Assets | 1.1B | 827.3M | 626.6M | 449.6M | 317.0M | 606.2M | |
Capital Stock | 2.4M | 2.6M | 2.8M | 2.9M | 156K | 148.2K | |
Net Working Capital | 992.3M | 685.7M | 512.6M | 355.8M | 205.7M | 352.2M | |
Short Term Debt | 12.7M | 3.8M | 6.1M | 7.9M | 3.7M | 6.3M | |
Intangible Assets | 55.5M | 152.4M | 135.0M | 120.2M | 101.5M | 107.4M | |
Common Stock | 2.4M | 2.6M | 2.8M | 2.9M | 156K | 148.2K |
American Well Key Income Statement Accounts
2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
Tax Provision | 639K | (5.4M) | 64K | 3.2M | 2.8M | 2.9M | |
Net Interest Income | 1.6M | 120K | 6.1M | 15.3M | 10.8M | 6.6M | |
Interest Income | 1.6M | 120K | 6.1M | 15.3M | 10.8M | 6.6M | |
Interest Expense | 1.6M | 120K | 6.1M | 19.4M | 22.3M | 23.5M | |
Total Revenue | 245.3M | 252.8M | 277.2M | 259.0M | 254.4M | 243.8M | |
Gross Profit | 88.5M | 104.3M | 116.8M | 94.8M | 99.0M | 98.6M | |
Operating Income | (227.4M) | (179.1M) | (275.9M) | (692.1M) | (217.5M) | (228.4M) | |
Ebit | (227.9M) | (179.0M) | (276.5M) | (257.9M) | (217.5M) | (228.4M) | |
Research Development | 84.4M | 106.6M | 138.5M | 105.8M | 86.1M | 96.1M | |
Ebitda | (216.9M) | (162.2M) | (249.7M) | (226.0M) | (184.6M) | (193.8M) | |
Cost Of Revenue | 156.8M | 148.5M | 160.4M | 164.3M | 155.4M | 145.2M | |
Income Before Tax | (225.8M) | (179.0M) | (269.7M) | (672.7M) | (206.8M) | (217.1M) | |
Net Income | (226.4M) | (173.7M) | (269.8M) | (675.2M) | (208.1M) | (218.6M) | |
Income Tax Expense | 639K | (5.4M) | 64K | 3.9M | 2.8M | 2.9M | |
Minority Interest | 22.1M | 448K | 1.6M | 3.0M | 4.5M | 4.3M |
American Well Key Cash Accounts
2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
Change To Inventory | (6.0M) | 1.6M | (1.2M) | 2.1M | 1.9M | 2.0M | |
Investments | (66.8M) | 97.5M | (11.6M) | 126.2M | (18.7M) | (17.7M) | |
Change In Cash | 803.9M | (195.5M) | (207.9M) | (166.5M) | (143.7M) | (136.5M) | |
Free Cash Flow | (115.8M) | (142.1M) | (202.8M) | (163.6M) | (127.3M) | (133.7M) | |
Depreciation | 10.2M | 16.1M | 26.2M | 31.9M | 33.0M | 20.5M | |
Other Non Cash Items | 2.3M | 9.3M | 16.5M | 438.4M | (127.1M) | (120.7M) | |
Capital Expenditures | 3.3M | 559K | 10.4M | 15.2M | 15.2M | 16.0M | |
Net Income | (228.6M) | (176.8M) | (272.1M) | (675.2M) | (208.1M) | (218.6M) | |
End Period Cash Flow | 942.7M | 747.2M | 539.3M | 372.8M | 229.1M | 217.7M | |
Change To Netincome | 10.3M | 118.0M | 43.7M | 68.2M | 78.5M | 54.8M |
American Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining American Well's current stock value. Our valuation model uses many indicators to compare American Well value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across American Well competition to find correlations between indicators driving American Well's intrinsic value. More Info.American Well Corp is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . At this time, American Well's Return On Equity is quite stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value American Well by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.American Well Corp Systematic Risk
American Well's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. American Well volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was five with a total number of output elements of fifty-six. The Beta measures systematic risk based on how returns on American Well Corp correlated with the market. If Beta is less than 0 American Well generally moves in the opposite direction as compared to the market. If American Well Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one American Well Corp is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of American Well is generally in the same direction as the market. If Beta > 1 American Well moves generally in the same direction as, but more than the movement of the benchmark.
Today, most investors in American Well Stock are looking for potential investment opportunities by analyzing not only static indicators but also various American Well's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of American Well growth as a starting point in their analysis.
Price Earnings To Growth Ratio |
|
American Well March 22, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of American Well help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of American Well Corp. We use our internally-developed statistical techniques to arrive at the intrinsic value of American Well Corp based on widely used predictive technical indicators. In general, we focus on analyzing American Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build American Well's daily price indicators and compare them against related drivers.
Information Ratio | (0.02) | |||
Maximum Drawdown | 30.99 | |||
Value At Risk | (6.98) | |||
Potential Upside | 7.67 |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in American Well Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in housing. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of American Well. If investors know American will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about American Well listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (13.88) | Revenue Per Share | Quarterly Revenue Growth 0.005 | Return On Assets | Return On Equity |
The market value of American Well Corp is measured differently than its book value, which is the value of American that is recorded on the company's balance sheet. Investors also form their own opinion of American Well's value that differs from its market value or its book value, called intrinsic value, which is American Well's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because American Well's market value can be influenced by many factors that don't directly affect American Well's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between American Well's value and its price as these two are different measures arrived at by different means. Investors typically determine if American Well is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, American Well's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.